Anteris Technologies (ASX:AVR) Research & Development : A$22.85 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Anteris Technologies's Research & Development for the six months ended in Dec. 2023 was A$13.16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$22.85 Mil.

Anteris Technologies Research & Development Historical Data

The historical data trend for Anteris Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Research & Development Chart

Anteris Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

3.32

4.63

8.01

13.21

22.85

Anteris Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial															4.98	6.29	6.93	9.69	13.16

Anteris Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$22.85 Mil.

Anteris Technologies (ASX:AVR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Anteris Technologies Research & Development Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Anteris Technologies (ASX:AVR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (ASX:AVR) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

AMEUF:USA

Address

Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066

Website

https://www.anteristech.com

Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.

Anteris Technologies (ASX:AVR) Headlines

No Headlines